Source: Future Medicinal Chemistry. Unidades: FCFRP, FFCLRP
Subjects: ANTIVIRAIS, MEDICAMENTO, COVID-19, BANCO DE DADOS, AVALIAÇÃO DE MEDICAMENTOS, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEDERICO, Leonardo Bruno et al. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, v. 13, n. 16, p. 1353-1366, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0025. Acesso em: 07 nov. 2024.APA
Federico, L. B., Silva, G. M. da, Melim, L. I. da S. H., Gomes, S. Q., Barcelos, M. P., Francischini, I. A. G., & Silva, C. H. T. de P. da. (2021). Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening. Future Medicinal Chemistry, 13( 16), 1353-1366. doi:10.4155/fmc-2021-0025NLM
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4155/fmc-2021-0025Vancouver
Federico LB, Silva GM da, Melim LI da SH, Gomes SQ, Barcelos MP, Francischini IAG, Silva CHT de P da. Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening [Internet]. Future Medicinal Chemistry. 2021 ; 13( 16): 1353-1366.[citado 2024 nov. 07 ] Available from: https://doi.org/10.4155/fmc-2021-0025